Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-28

Clinical Trial Update: Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED [Phase 3]

View source ↗

Summary

Phase 3 trial comparing once-daily vardenafil, vardenafil PRN, and placebo in men after nerve-sparing prostatectomy to improve erectile dysfunction, focusing on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vardenafil (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction, Sexual Dysfunction, Physiological | Phase 3 | Status: COMPLETED